lersivirine
Jump to navigation
Jump to search
Indications
- treatment of HIV1
Dosage
Notes
- in clinical trials
More general terms
References
- ↑ Vernazza P et al. Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment - naive HIV-1 - patients: Week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial. J Acquir Immune Defic Syndr 2013 Feb 1; 62:171. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23328090